The encouraged generic drugs selected by Chinese authorities can benefit from preferential policy support in terms of review and approval, clinical trials and critical generic technology researches.
131 results
Log in to view more data, Log in now
| SN | Drug Name | Dosage Form | Strength | Source |
| 3-18 | view | Extended-release Injection |
1.6 ml: 0.441 g
|
The 3rd Batch of Encouraged Generic Drugs |
| 3-19 | view | Tablet |
0.2 g
|
The 3rd Batch of Encouraged Generic Drugs |
| 3-19 | view | Tablet |
50 mg
|
The 3rd Batch of Encouraged Generic Drugs |
| 3-20 | view | Sublingual Tablet |
10 mg
|
The 3rd Batch of Encouraged Generic Drugs |
| 3-20 | view | Sublingual Tablet |
5 mg
|
The 3rd Batch of Encouraged Generic Drugs |
| 3-20 | view | Sublingual Tablet |
2.5 mg
|
The 3rd Batch of Encouraged Generic Drugs |
| 3-21 | view | Tablet |
30 mg: 20 mg olanzapine and 10 mg samidorphan
|
The 3rd Batch of Encouraged Generic Drugs |
| 3-21 | view | Tablet |
25 mg: 15 mg olanzapine and 10 mg samidorphan
|
The 3rd Batch of Encouraged Generic Drugs |
| 3-21 | view | Tablet |
20 mg: 10 mg olanzapine and 10 mg samidorphan
|
The 3rd Batch of Encouraged Generic Drugs |
| 3-21 | view | Tablet |
15 mg: 5 mg olanzapine and 10 mg samidorphan
|
The 3rd Batch of Encouraged Generic Drugs |